Amneal Pharmaceuticals, Inc. is a global pharmaceutical company, which develops, manufactures, markets and distributes a portfolio of essential medicines. Its Generics segment includes a retail and institutional portfolio of over 270 product families covering a range of dosage forms and delivery systems, including both immediate and extended-release oral solids, powders, liquids, sterile injectables, nasal sprays, inhalation and respiratory products, biosimilar products, ophthalmic, films, transdermal patches and topicals. Its Specialty segment is engaged in the development, promotion, sale and distribution of branded pharmaceutical products, with a focus on products addressing central nervous system disorders, including Parkinson’s disease and endocrine disorders. Its AvKARE segment provides pharmaceuticals, medical and surgical products and services primarily to governmental agencies, predominantly focused on the U.S. Department of Defense and the U.S. Department of Veterans Affairs.
종목 코드 AMRX
회사 이름Amneal Pharmaceuticals Inc
상장일Nov 18, 2009
CEOMr. Chintu Patel
직원 수8100
유형Ordinary Share
회계 연도 종료Nov 18
주소400 Crossing Boulevard, 3rd Floor
도시BRIDGEWATER
증권 거래소NASDAQ Global Select Consolidated
국가United States of America
우편 번호08807
전화19089473120
웹사이트https://amneal.com/
종목 코드 AMRX
상장일Nov 18, 2009
CEOMr. Chintu Patel
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.

데이터 없음